Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel genomic variance of BRAF1 in papillary thyroid carcinoma: A case report.

Medicine - 19 Jan 2024

Wang Yuguo, Zhao Jian, Tan Zhihan, Du Jing, Zhang Linping, Xu Ying, Li Xiuying, Cai Yun, Wang Hui, Jiang Jianjun

Abstract excerpt

RATIONALE: Papillary thyroid carcinoma (PTC), the predominant subtypes accounting for approximately 85% of thyroid carcinomas, has a rapidly increasing global incidence rate. Statistically, approximately 74.6% PTC patients had the genomic variants of BRAF, especially BRAFV600E mutation, which has been reported to stratify patients and guide clinic-therapies. However, some PTC patients may carry other nonclassical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to Hyperplasia
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38241570
DOI: 10.1097/MD.0000000000036978
PMCID: PMC10798735

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel genomic variance of BRAF1 in papillary thyroid carcinoma: A case report.PMID 38241570Read ↗

A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.Semantic proximity Read ↗

BRAF V600E Mutation in Thyroid Carcinoma: A Large-Scale Study in Han Chinese PopulationSemantic proximity Read ↗

BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population.Semantic proximity Read ↗

Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma.Semantic proximity Read ↗

Association of BRAF V600E Allele Frequency With Clinicopathologic Outcomes in Papillary Thyroid CancerSemantic proximity Read ↗

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.Semantic proximity Read ↗

Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.Semantic proximity Read ↗

Clinic Study on the Relationship Between BRAF V600E Mutation and Outcomes of Microwave Ablation in Papillary Thyroid Carcinoma: A Propensity Score-matched Cohort Study.Semantic proximity Read ↗

The genomic landscape of papillary thyroid carcinoma on next-generation sequencing in patients undergoing total thyroidectomy.Semantic proximity Read ↗

Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification.Semantic proximity Read ↗

Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study.Semantic proximity Read ↗

Relationship between the BRAF-V600E variant allele frequency and clinicopathological characteristics of papillary thyroid carcinoma and its clinical applicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.